Skip to main content

Table 1 Baseline characteristics of study participants at initiation of nevirapine-based antiretroviral therapy

From: Cytochrome P450 2B6 genetic variants are associated with plasma nevirapine levels and clinical response in HIV-1 infected Kenyan women: a prospective cohort study

Characteristic

Median (IQR) or N (%)

Age (yrs)

36 (32–40)

Weight (kg)

65 (54 – 70)

BMI (kg/m2)

25.0 (22.3 – 28.2)

CD4 cell count (cells/μL)

126 (79 – 154)

Plasma viral load (log10 copies/mL)

5.54 (5.17 – 5.90)

Cervical viral load (log10 copies/mL)

4.04 (3.42 – 4.60)

ALT levels (>ULN)

11 (15.9)

Skin rash

11 (15.9)

Plasma resistance (present)

0

Genital resistance (present)

0

ART regimen: d4T/3TC/NVP

69 (100)

  1. BMI = body mass index, ALT = alanine aminotransferase, ULN = upper limit of normal, ART = antiretroviral therapy, NVP = nevirapine, d4T = stavudine, 3TC = lamivudine.